Photodamage to the mitochondria of murine leukemia P388 cells resulted in immediate loss of the mitochondrial membrane potential together with the release of cytochrome c into the cytosol. This was followed by a rapid activation of caspase 3-like proteases, as indicated by a marked rise in DEVDase activity. There was no significant effect on WEHDase or VEIDase activities, suggesting that only the late-stage caspases had been effected. The apoptotic response to mitochondrial photodamage was abolished by the broadspectrum caspase inhibitor zVAD-fmk, but this did not prevent loss of viability after mitochondrial photodamage. These studies indicate that the release of cytochrome c from photodamaged mitochondria is sufficient to directly initiate a caspase-dependent apoptotic response.
Introduction
An important cell-death pathway involves the release of cytochrome c from mitochondria to the cytosol, thereby triggering caspase-3 activation, and initiation of the apoptotic program at a relatively late stage. 1±3 Supporting evidence for this hypothesis was provided by experiments which established that microinjection of cytochrome c into intact cells could induce an apoptotic response. 4, 5 The loss of mitochondrial cytochrome c from cells stimulated to undergo apoptosis was associated with a loss of the mitochondrial membrane potential (~C m ). While a mechanism for the initiation of the apoptotic program by cytosolic cytochrome c has been described, 6 the existence of other programmed cell death mechanisms is suggested by demonstrations of apoptosis without the appearance of cytosolic cytochrome c, 7, 8 and the failure of the microinjection procedure to initiate an apoptotic response in some cell lines. 4 In this study, we examined factors relating to the initiation of a rapid apoptotic response by photodynamic therapy (PDT). PDT is an FDA-approved form of cancer therapy involving the somewhat selective photosensitization of neoplastic cells, usually with porphyrins or porphyrin-like drugs. The delivery of a suitable light dose to photosensitized tissues can result in a highly-localized eradication of neoplastic lesions 9 with minimal damage to adjacent host tissues. Several groups have now reported that PDT can initiate a rapid apoptotic response.
10±13
Rapid appearance of caspase-3 activity, along with PARP cleavage, has been reported after PDT in vitro. 13±15 The mode of cell death (apoptosis vs necrosis) appears dependent on the cell line, the photosensitizing agent and the protocol. 11, 16, 17 The critical determinants may relate to sites of sensitizer localization which may be a function of both the sensitizer and the cell type. We have reported that a supra lethal PDT dose can cause a necrotic response, as judged from the pattern of DNA fragmentation on agarose gels. 15 The latter result may derive from photodamage to membranes, leading to leakage of cytosolic components, or from photodamage to caspases, cytochrome c and other components of the apoptotic process.
While some photosensitizing agents target multiple sub-cellular sites, agents with selective affinity for specific organelles can be used to produce highlylocalized photodamage. Because of the very short lifetime of singlet oxygen, the product formed by the photodynamic process, cytotoxicity subsequent to irradiation is confined to initial sites of drug localization. 18 We have reported that an apoptotic response in murine leukemia cell lines occurs after mitochondrial photodamage, but not when mitochondria are spared and lysosomal and/or membrane sites are affected. 19, 20 In the current study, we employed two porphycenes which mediate mitochondrial photodamage while sparing lysosomes and the plasma membrane. The porphycenes represent a modification of the porphyrin structure with some advantageous photophysical properties. 21 Initial studies were carried out with the porphycene monomer termed PcM, 20 but to insure that the results were not unique to a single drug, we have identified a second mitochondria-specific porphycene derivative (capronyloxy porphycene, CPO) described by Toledano et al. 22 In this report, we provide information on the consequences of mitochondrial photodamage which result in the initiation of the apoptotic program. We also examined the effects of very high concentrations of these porphycenes in the dark, to provide an explanation for a previous observation that PcM can produce an apoptotic response under these conditions.
20,23

Results
Results described here were mainly acquired using the porphycene PcM, but identical results were obtained with CPO. All studies reported involved at least three repetitions of the experiments described, so that statistical interpretations were feasible. Murine leukemia P388 cells in culture were used throughout. Unless otherwise specified, conditions used in these experiments resulted in a 90% reduction of cell viability from photodynamic effects.
Effects of photodamage on mitochondria, DC m and cytochrome c release
Porphycene-induced photodamage resulted in an immediate loss of DC m , as detected by the fluorescent probe MTO, a marker for the mitochondrial membrane potential (Figure 1) . Results obtained by fluorescence microscopy provide a qualitative evaluation of mitochondrial alterations with the results suggesting an`all-or-none' phenomenon. Under conditions that resulted in a 92+5% loss of viability, less than 5% of the mitochondria retained the fibrillar fluorescence pattern observed with control cells. In these experiments, the incubation temperature never exceeded 108C after irradiation, permitting delineation of the effects of photodamage on DC m without the intervention of any temperature-sensitive step. Loss of the characteristic MTO labeling pattern is therefore a direct result of the photodynamic process. The nonyl acridine orange (NAO) labeling pattern remained unchanged after mitochondrial photodamage. This indicates that the organelle structure was preserved, since NAO labels mitochondria independent of DC m 24 via an interaction with cardiolipin. 25 Using Western blots, we demonstrated that cytochrome c was released into the cytosol immediately after the irradiation of porphycene-sensitized cells at 108C ( Figure  2 ). The control (lane A) provides an estimate of the extent of mitochondrial contamination and/or base-line mitochondrial damage in the cell extracts used in this assay. After PDT, the concentration of cytosolic cytochrome c continued to increase during a subsequent incubation at 378C, and was further enhanced by the presence of 100 nM staurosporin, an agent which potentiated the apoptotic response to PDT.
Dark toxicity of the porphycenes
Under conditions employed in the PDT studies, the porphycenes did not initiate apoptosis in the absence of light, as indicated by the appearance of apoptotic nuclei detected by HO342 labeling. Exposure of cells for 15 min at 378C to a 20 mM concentration of either porphycene in the dark resulted in loss of the characteristic MTO labeling pattern ( Figure 3 ) while the NAO labeling patterns remained unaffected (not shown). We also observed a time-dependent increase in DEVDase activity. Implications of these results are explored in the Discussion section.
Caspase activation
After irradiation of cells loaded with a 2 mM concentration of either porphycene, subsequent incubation at 378C resulted in a rapid increase in DEVDase activity which ultimately reached a peak value of 90 U/mg cells. There was no change in WEHDase or VEIDase activities (data obtained with PcM are shown in Figure 4A ). Levels of WEHDase and VEIDase never deviated from baseline (0.15+0.05 U/mg cells). The broadspectrum caspase inhibitor zVAD-fmk (10 mM), added during the porphycene-loading incubation, inhibited the increase of DEVDase activity after mitochondrial photodamage ( Figure  4 ), and inhibited both chromatin and cellular fragmentation ( Figure 5 ), but did not prevent the loss of DC m after PDT ( Figure 6 ), nor was cell viability restored (Table 1 ). These results indicate that caspase activation is needed for the appearance of an apoptotic morphology, but not for the loss of DC m which follows mitochondrial photodamage. The irreversible inhibition of caspase activation by zVAD-fmk did not, however, promote the viability of cells after an LD 50 PDT dose with either porphycene (Table 1) . Exposure of cells to 20 mM levels of either porphycene also resulted in an increase in DEVDase activity ( Figure  4B ). In these studies, cell samples were periodically withdrawn during an incubation at 378C, washed free from the sensitizers and assayed for caspase activity.
Effects of staurosporin on apoptosis and tyrosine phosphorylation
A 100 nM concentration of the protein kinase inhibitor staurosporin caused a marked potentiation of the apoptotic response to mitochondrial photodamage ( Figure 7 ). This study was carried out using a light dose which reduced cell viability by approximately 50%; addition of staurosporin promoted the cytotoxic effect ( Table 1 ). The number of apoptotic cells 60 min after irradiation was increased from 38+4% to 67+5% when staurosporin was present, and there Exposure of P388 cells to 100 nM staurosporin for 60 min did not result in the appearance of apoptotic cells, although prolonging the time to 24 h resulted in a 40 ± 50% apoptotic population. These results indicate that the enhanced apoptotic response shown in Figure 7 is related to staurosporin-induced promotion of PDT-induced apoptosis.
The most prominent protein phosphorylation associated with PDT involves a tyrosine residue on a 75 ± 80 kDa protein which reaches a maximal level 30 min after irradiation (Figure 8 ). When 100 nM staurosporin was present during the drug-loading incubation, the PDTassociated tyrosine phosphorylation was inhibited ( Figure  8 ).
Discussion
In this report, we show that photodamage catalyzed by either of two porphycenes leads to loss of the mitochondrial membrane potential, release of cytochrome c into the cytosol, a marked increase in DEVDase activity, cellular fragmentation and the appearance of apoptotic nuclei. The broad-spectrum caspase inhibitor zVAD-fmk 26 abolished both apoptosis and the ensuing cell fragmentation ( Figure 5 ), although the resulting loss of viability was not reversed. (Table  1) . These results are interpreted to mean that cells which have had sufficient mitochondrial photodamage to abolish DC m will ultimately die, although not via an apoptotic process. A similar phenomenon was reported by Lemaire et al; 27 suppression of apoptosis by z-D-cmk or zVAD-fmk resulted in necrotic cell death.
The porphycenes used in this study are the most specific mitochondrial photosensitizing agents we have identified. Although we cannot yet exclude the possibility that these agents cause photodamage at additional subcellular loci, studies with a series of fluorescent probes indicate that neither PcM 20 nor CPO (unpublished) target lysosomes or the cell membrane. We had previously reported that apoptosis can be induced by agents that target mitochondria or mitochondria and lysosomes, but not after membrane or lysosomal photodamage. 20 A unique property of PDT is that photodamage does not occur until photosensitized cells are irradiated. When irradiation occurs at reduced temperatures, effects of photodamage can be observed in the absence of subsequent enzymatic reactions. The immediate loss of DC m (Figure 1 ) is interpreted to reflect a direct consequence of mitochondrial photodamage. These results are consistent with reports implicating the mitochondrion as a source of factors which initiate an apoptotic response. 1, 2, 28, 29 Since mitochondrial photodamage results in a prompt loss of DC m , the apoptogenic effects of PDT are not necessarily comparable to those from other stimuli, where the loss of DC m can occur after the release of cytochrome c into the cytosol. 30 The altered MTO labeling pattern that occurs when cells are maintained at 108C during and after irradiation (Figure 1 ) make it unlikely that protease activation plays a role in the loss of DC m .
We had previously shown that PDT with the sensitizer aluminum phthalocyanine initiated PARP cleavage within 10 min, an effect which suggests rapid caspase activation. A more direct proof is provided here, using a fluorogenic tetrapeptide substrate optimized for caspase 3-like proteases. 31 The release of cytochrome c after irradiation (Figure 2 ) was sufficient to initiate a rapid increase in DEVDase activity (Figure 4 ). Other demonstrations of rapid caspase activation after PDT have been reported. 13, 14 In an earlier report, Enari et al 32 utilized two fluorogenic tetrapeptide caspase substrates to explore the sequence of activation of caspase-1 and -3. In the present study, we similarly used WEHD-amc, an optimal or near-optimal substrate for caspases 1, 4 and 5, and VEID-amc, a substrate for caspase-6 and -8. 31 The lack of activity above control values suggests that these proteases are not activated after mitochondrial photodamage, assuming that these substrates will detect the activity of the respective caspases. In a study involving HL-60 cells and a different photosensitizing agent, 13 also detected activation of caspase-3 but not caspase-1.
At a 100 nM level, the protein kinase inhibitor staurosporin markedly promoted the apoptotic response to mitochondrial photodamage ( Figure 7 , Table 1 ), as well as release of cytochrome c from mitochondria ( Figure 2 ). This was accompanied by inhibition of the PDT-induced phosphorylation of a tyrosine residue on an *80 kDa protein ( Figure 8 ). This protein was identified as HS1 by Xue et al 33 and it was postulated that enhanced phosphorylation of this protein might serve to protect cells from the lethal effects of PDT. The results described here are consistent with this hypothesis: inhibition of HS1 phosphorylation was associated with an enhanced apoptotic response. Although there have been reports that PDT can initiate other signal-transduction events, 17 we propose that the release of mitochondrial cytochrome c alone is sufficient for the triggering of an apoptotic response. Granville et al 34 recently reported a similar effect of staurosporin; PDT-induced phosphorylation of a 4200 kDa protein was inhibited by a significantly higher (3.2 mM) level of staurosporin. These studies were carried out with the P815 mouse leukemia and a different sensitizer. Unlike results reported here, only a slight promotion of the apoptotic effects of PDT resulted from this high-dose of staurosporin.
Earlier studies indicated that exposure of P388 cells to a 20 mM extracellular porphycene concentration resulted in the initiation of apoptosis in the dark. 20, 23 At this drug concentration, 20-fold higher than the level used to catalyze photodamage, we observed a fall in DC m (Figure 3) , along with transfer of cytochrome to the cytosol (not shown) and promotion of DEVDase activity ( Figure 4B ). The latter effect resulted in a sigmoidal curve, resulting from the autocatalytic effect of a gradual release of cytochrome c as mitochondrial damage proceeds. In contrast, the increase in DEVDase activity after photodamage to a substantial number of mitochondria was more rapid and lacked the`lag' phase ( Figure 4A ). It is interesting to note that protoporphyrin, a photosensitizing agent that binds to the mitochondrial peripheral benzodia- zepine receptor, also causes a`dark' mitochondrial permeability transition. 35, 36 Henderson et al 37 recently examined a series of porphyrin analogs and reported that the most potent of these showed a strong affinity for a site on albumin that also binds benzodiazepine receptor antagonists. 38 These results suggest that the affinity of certain photosensitizing agents for the peripheral benzodiazepine receptor may account for the targeting of mitochondria for photodamage.
Ellerby et al 39 have proposed three mechanisms for the initiation of apoptosis: Pre-mitochondrial inducers, e.g., tamoxifen, can initiate a signal transduction cascade resulting in release of mitochondrial factors which initiate apoptosis. This class of agents includes most common anti-tumor agents and perhaps ionizing radiation; Mitochondrial inducers, e.g., atractyloside, although nonpermeable, can act directly on isolated mitochondria to yield apoptosis-inducing factors; Post-mitochondrial inducers, represented by cytochrome c, initiate apoptosis in a cell-free system lacking mitochondria. Hickman et al 40 and Fearnhead et al 41 proposed that the apoptotic program is present in drug-resistant cell lines, with the pathway to apoptosis often inhibited by mutations which suppress apoptotic signals. Since mitochondrial perturbations sufficient to cause a release of cytochrome c can trigger apoptosis, mitochondria have been proposed as a potential target for cancer therapy 42 thereby providing a direct stimulus to apoptotic cell death. Using Ellerby's criteria, we propose that these porphycenes can be classified as`permeable' mitochondrial inducers of apoptosis. The broad spectrum of tumor responses to PDT 9 would then result from the initiation of apoptosis at such a late stage that impaired signal transduction pathways are bypassed.
Materials and Methods
Cells and cell culture
Murine leukemia P388 cells were maintained in Fischer's medium (Gibco-BRL) supplemented with gentamicin, glutamine, and 10% horse serum. Cells were collected by centrifugation during the exponential period of growth. The wet weight of the cell pellet was determined, and the cells were then resuspended in growth medium (buffered with 20 mM HEPES at pH 7.2) at a density of 7 mg/ml. Chemicals DEVD-amc, WEHD-amc, DEVD-fmk and zVAD-fmk were purchased from Enzyme Systems Products, Livermore, CA, USA. Two porphycenes were used for mitochondrial photosensitization, PcM 23 and CPO 22 . Fluorescent dyes (MTO, NAO and HO342) were provided by Molecular Probes, Eugene, OR, USA.
Incubation and irradiation
Cell suspensions were incubated with PcM or CPO porphycenes (final concentration=2 mM) for 15 min at 378C, collected by centrifugation and suspended in fresh medium. Where specified, 10 mM zVAD-fmk was present during the initial incubation. In some experiments, MTO or NAO (10 mg/ml) was present during the loading incubation. Irradiation was carried out at 108C to minimize temperature-dependent metabolic processes.
The light source was a 600 watt quartz-halogen lamp with the output filtered through a 10 cm layer of water to remove wavelengths 4900 nm. The bandwidth was further limited by a heat-absorbing filter (bandpass=400 ± 850 nm) and an interference filter (620+10 nm). The light dose was adjusted to decrease viability of photosensitized cells to 50% of controls (1.5 J/cm 2 ), or to 10% of control (4.5 J/cm 2 ). The light flux was measured with a calibrated EG&G model 450 radiometer. After irradiation, the cells were treated as described below. Cell viability was determined by clonogenic assays (plating efficiency 480%). In some experiments, we assessed the dark toxicity resulting from a 15 min incubation at 378C using 20 mM levels of the porphycenes. The cells were never exposed to light, but immediately used for further experiments as outlined below.
Fluorescence microscopy
Direct effects of irradiation on the mitochondrial membrane potential DC m were determined by labeling with MTO (10 mg/ml). Mitochondrial damage was assessed with the probe NAO (10 mg/ml). To eliminate the need for warming the cells after irradiation, these probes were added during the first incubation. Effects of mitochondrial photodamage on DC m could thereby be assessed on cells that were at no time exposed to temperatures 4108C during or after irradiation. MTO fluorescence (580 ± 620 nm) was detected upon excitation at 510 ± 560 nm. NAO fluorescence was determined using excitation at 470 ± 500 nm and measuring emission at 515 ± 530 nm. A 600 nm low-pass filter was inserted into the excitation path to minimize transmission of IR to the CCD camera.
For the detection of apoptotic nuclei, cells were diluted to a density of 4610 5 /ml after irradiation, and incubated at 378C, usually for 60 min. The cells were then collected and labeled with MTO+HO342 (2 mg/ml). After 5 min at 378C, the cells were collected by centrifugation and the percentage of apoptotic nuclei were determined by fluorescence microscopy (three fields of 100 cells each). HO342 fluorescence (420 ± 450 nm) was detected upon excitation at 330 ± 380 nm. There was no crossover between HO342 and MTO fluorescence under these conditions. All fluorescence studies were carried out using a Nikon Labophot microscope fitted with a digital CCD camera (Photometrics, Tucson, AZ, USA). A 600 nm low-pass filter was inserted into both the excitation path and the CCD camera entry port to reduce transmission of infra-red light from the mercury source which will otherwise fog the CCD detector, Images were processed with MetaMorph software (Universal Imaging Corp., West Chester, PA, USA).
Caspase assays
Cell pellets (2610 6 cells) were collected at intervals after incubation at 378C following irradiation and lysed in 50 mM Tris buffer pH 7.5 containing 0.03% Nonidet and 1 mM DTT. Nuclei were removed by low-speed centrifugation (8006g, 5 min) and the cytosol fraction was incubated with 40 mM DEVD-amc, WEHD-fmc or VEID amc, 10 mM HEPES pH 7.5, 50 mM NaCl and 2.5 mM DTT in a total volume of 200 ml for 120 min at 378C. Coumarin fluorescence, released by caspase activity, was measured using 360 nm excitation. Effects of porphycenes in the dark were determined using 20 mM drug levels. Cells were collected at intervals, washed free from extracellular drug, and the assay was carried out as defined above. A CCD device (Instaspec IV, Oriel, Statford, CT, USA) fitted with a monochromator was used to measure the fluorescence emission spectrum. The intensity at the optimum (approximately 450 nm) was measured. Units of enzyme activity are defined in terms of pmols of substrate hydrolyzed/mg cells/mg protein/60 min. In all cases, blank determinations were made (no cells, or cells without PDT). The system was initially calibrated with known levels of aminomethyl-or trifluoromethylcoumarin.
Effect of staurosporin on PDT-induced apoptosis
The photosensitizer loading incubation was carried out with both sensitizer and 100 nM staurosporin or 10 mM zVAD-fmk, for 15 min at 378C. The cells were then suspended in fresh medium, irradiated and incubated in fresh medium for 60 min at 378C, then labeled with HO342 as described above. To assess both apoptosis and cell fragmentation, we also acquired phase-contrast images of the same fields.
Western blots for cytochrome c and phosphotyrosine
Release of cytochrome c from mitochondria was assessed using control cells and cells collected at intervals during a second incubation at 378C following irradiation, using PcM or CPO. Pellets were collected and gently homogenized in buffer containing sucrose, with nuclei and mitochondria removed by centrifugation. 2 The resulting cytosolic preparations were analyzed on 15% gels and the presence of cytochrome c determined using an anti-cytochrome c MAb described by Jemmerson et al. 43 Phosphotyrosine residues were detected by a similar procedure. The procedure was based on the method used by Kanakura et al. 44 Cells were incubated for 20 min at 48C in a Tris-based lysis buffer containing NaCl, glycerol, 1% Nonidet P-40, 10 mM EDTA, and several protease inhibitors, along with NaF and the tyrosine phosphatase inhibitor sodium orthovanadate. A mixture of three phosphotyrosine probes was used (Zymed Labs, South San Francisco, CA, USA): PY-7EI, PY-1B2 & PY20. After immunoblotting, the remaining binding sites on the filter were blocked by treatment with fat-free milk (MLK), and the PVDF membrane incubated overnight with antibody in TBS buffer containing MLK, washed and incubated in TBS-MLK buffer containing goat anti-mouse IgG linked to alkaline phosphatase. Gel images were visualized by a fluorogenic procedure using the Molecular Dynamics`STORM' imaging system.
